UBS Group’s Moolec Science MLEC Stock Holding History

UBS Group’s Portfolio MLEC Stock Details MLEC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12	Buy	+2	New	+$16	﹤0.01%	10320
2025 Q4	–	Sell	-700	Closed	-$10.3K	–	10929
2025 Q3	$10.3K	Buy	+700	New	+$28.2K	﹤0.01%	8548
2025 Q2	–	Sell	-13	Closed	-$1.08K	–	10623
2025 Q1	$1.08K	Sell	13 -10	-43%	-$1.14K	﹤0.01%	9581
2024 Q4	$2.81K	Sell	23 -96	-81%	-$12.4K	﹤0.01%	8983
2024 Q3	$15.7K	Buy	119 +51	+75%	+$7.12K	﹤0.01%	7501
2024 Q2	$11.2K	Buy	68 +21	+45%	+$3.98K	﹤0.01%	7655
2024 Q1	$9.72K	Buy	+47	New	+$13K	﹤0.01%	7267
2023 Q4	–	Hold	0	–	-$129	–	9678
2023 Q3	–	Hold	0	–	–	–	8826
2023 Q2	–	Sell	-12	Closed	-$7.17K	–	9370
2023 Q1	$7.17K	Buy	+12	New	+$10.8K	﹤0.01%	7839

Other funds holding MLEC

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

UBS Group's MLEC Position: Q1 2026 in Review

UBS Group opened a new position in Moolec Science (MLEC) in Q1 2026: 2 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #10320 among its holdings. This is a return to the name: UBS Group previously reported a position in MLEC as recently as Q3 2025.

UBS Group first reported a position in MLEC in Q1 2023 and has held it in 8 quarters since. The position peaked at $15.7K in Q3 2024. 3 funds tracked by Wall St. Rank hold MLEC as of Q1 2026.

UBS Group held 2 shares of Moolec Science worth $12 as of Q1 2026.
Moolec Science was a new UBS Group position in Q1 2026.
Moolec Science made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #10320 holding.
UBS Group first reported a position in Moolec Science in Q1 2023 and has held it in 8 quarters since.
UBS Group's Moolec Science position peaked at $15.7K in Q3 2024.
3 funds tracked by Wall St. Rank held Moolec Science as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.